Referred to Cascade by a former client, Compass Healthcare sought to divest its cancer treatment and related clinical operations to ensure the long-term success of the practice while refocusing resources on its core specialties.

Cascade guided the transaction through a complex carve-out of two clinical practices, leveraging creative problem-solving, stakeholder education, and collaborative deal structuring to navigate the numerous challenges involved in integrating those practices with the buyer. The result was a seamless transition that strengthened the community's oncology and broader patient care capabilities, enabled Compass Healthcare to concentrate on its core focus areas, and ensured continuity of high-quality urological and cancer care for patients in the region.

The transaction was led by Rajesh Kothari, Chair of the Board and Managing Director. Read the press release.

contacts

Harry Cendrowski

publications

GCG Deal Announcement | Cascade Partners LLC advised Lansing Institute of Urology